Analysed ANIXA BIOSCIENCES INC (ANIX:NASDAQ) News Sources
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
06-04-2026
yahoo.com
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
07-04-2026
yahoo.com
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
09-04-2026
yahoo.com
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
10-04-2026
yahoo.com
Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference
15-04-2026
marketbeat.com
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
22-04-2026
yahoo.com
Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
29-04-2026
yahoo.com
Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
01-05-2026
yahoo.com
What is the current price of ANIXA BIOSCIENCES INC (ANIX:NASDAQ)?
The current price of ANIXA BIOSCIENCES INC (ANIX:NASDAQ) is $2.65.
ANIXA BIOSCIENCES INC (ANIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANIXA BIOSCIENCES INC (ANIX:NASDAQ) since the previous trading day is $-0.08.
ANIXA BIOSCIENCES INC (ANIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANIXA BIOSCIENCES INC (ANIX:NASDAQ) since the previous trading day is -2.9304%.
What is the most recent average sentiment score for ANIXA BIOSCIENCES INC (ANIX:NASDAQ)?
The most recent average sentiment score for ANIXA BIOSCIENCES INC (ANIX:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ANIXA BIOSCIENCES INC (ANIX:NASDAQ)?
The most recent sentiment for ANIXA BIOSCIENCES INC (ANIX:NASDAQ) is .
SEC-8K** Filing Available For ANIXA BIOSCIENCES INC (ANIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.